Intelligent Bio Solutions Inc
NASDAQ:INBS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Intelligent Bio Solutions Inc
NASDAQ:INBS
|
US |
|
Interlink Electronics Inc
NASDAQ:LINK
|
US |
Intrinsic Value
The intrinsic value of Intelligent Bio Solutions Inc (INBS) under the Base Case is 13.34 USD per share.
Compared with the current market price of 1.44 USD, the stock appears
Undervalued by 89% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Intelligent Bio Solutions Does
GBS, Inc. operates as a biosensor diagnostic technology company. The company is headquartered in New York City, New York and currently employs 12 full-time employees. The company went IPO on 2020-12-23. The firm is developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. The firm's Intelligent Bio Solutions is a biosensor platform, which is engaged in developing and launching diagnostic tests urgently needed to help people living with chronic diseases.
- Headquarters
- United States of America US
- Employees
- 12
- IPO date
- Dec 23, 2020
Revenue & Expenses Breakdown
Intelligent Bio Solutions Inc
Earnings Waterfall
Intelligent Bio Solutions Inc
The intrinsic value for Intelligent Bio Solutions Inc (INBS) under the Base Case is 13.34 USD.
Compared with the current market price of 1.44 USD, the stock appears Undervalued by 89% .